Close Menu

NEW YORK – Exagen today announced it has closed a financing round that raised $22.6 million.

The funds will go toward ongoing commercialization of the Vista, California-based firm's autoimmune tests and therapeutics promotion business, Exagen said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.